Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term enzymology. Found 132 abstracts

no pagination
Gupta MK, Gordon J, Glauser GM, Myers VD, Feldman AM, Cheung JY, Khalili K. Lamin B is a target for selective nuclear PQC by BAG3: implication for nuclear envelopathies. Cell death & disease. 2019 Jan 10;10(1):23.   PMCID: PMC6328609
Hamy AS, Tury S, Wang X, Gao J, Pierga JY, Giacchetti S, Brain E, Pistilli B, Marty M, Espie M, Benchimol G, Laas E, Lae M, Asselain B, Aouchiche B, Edelman M, Reyal F. Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial. J Clin Oncol. 2019 Mar 10;37(8):624-35.   PMCID: PMC6804843
Nanayakkara GK, Wang H, Yang X. Proton leak regulates mitochondrial reactive oxygen species generation in endothelial cell activation and inflammation - A novel concept. Archives of biochemistry and biophysics. 2019 Feb 15;662:68-74.   PMCID: PMC6800189
Ablain J, Xu M, Rothschild H, Jordan RC, Mito JK, Daniels BH, Bell CF, Joseph NM, Wu H, Bastian BC, Zon LI, Yeh I. Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science (New York, NY). 2018 Nov 30;362(6418):1055-60.   PMCID: PMC6475924
Arosarena OA, Barr EW, Thorpe R, Yankey H, Tarr JT, Safadi FF. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases. Journal of cellular physiology. 2018 Jan;233(1):409-21.   PMCID: PMC5592128
Choueiri TK, Plimack E, Arkenau HT, Jonasch E, Heng DY, Powles T, Frigault MM, Clark EA, Handzel AA, Gardner H, Morgan S, Albiges L, Pal SK. Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer. J Clin Oncol. 2017 Sep 10;35(26):2993-3001.
Di Meco A, Li JG, Blass BE, Abou-Gharbia M, Lauretti E, Pratico D. 12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice. Biological psychiatry. 2017 Jan 15;81(2):92-100.
Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J, Schiller JH, Mitchell-Richards K, Friedman PN, Ritter J, Milne G, Hahn OM, Stinchcombe TE, Vokes EE. Phase III Randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non-small-cell lung cancer with cyclooxygenase-2 overexpression: CALGB 30801 (Alliance). Journal of Clinical Oncology. 2017 Jul;35(19):2184-92.   PMCID: PMC5493050
Li JG, Barrero C, Merali S, Pratico D. Genetic absence of ALOX5 protects from homocysteine-induced memory impairment, tau phosphorylation and synaptic pathology. Human molecular genetics. 2017 May 15;26(10):1855-62.
Lu H, Liu S, Zhang G, Bin W, Zhu Y, Frederick DT, Hu Y, Zhong W, Randell S, Sadek N, Zhang W, Chen G, Cheng C, Zeng J, Wu LW, Zhang J, Liu X, Xu W, Krepler C, Sproesser K, Xiao M, Miao B, Liu J, Song CD, Liu JY, Karakousis GC, Schuchter LM, Lu Y, Mills G, Cong Y, Chernoff J, Guo J, Boland GM, Sullivan RJ, Wei Z, Field J, Amaravadi RK, Flaherty KT, Herlyn M, Xu X, Guo W. PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas. Nature. 2017 Oct 05;550(7674):133-6.   PMCID: PMC5891348
Dasgupta Y, Koptyra M, Hoser G, Kantekure K, Roy D, Gornicka B, Nieborowska-Skorska M, Bolton-Gillespie E, Cerny-Reiterer S, Muschen M, Valent P, Wasik MA, Richardson C, Hantschel O, van der Kuip H, Stoklosa T, Skorski T. Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases. Blood. 2016 Apr 28;127(17):2131-43.   PMCID: PMC4850868
Deng N, Hoyte A, Mansour YE, Mohamed MS, Fuchs JR, Engelman AN, Kvaratskhelia M, Levy R. Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies. Protein science : a publication of the Protein Society. 2016 Nov;25(11):1911-7.   PMCID: PMC5079246
Podszywalow-Bartnicka P, Cmoch A, Wolczyk M, Bugajski L, Tkaczyk M, Dadlez M, Nieborowska-Skorska M, Koromilas AE, Skorski T, Piwocka K. Increased phosphorylation of eIF2alpha in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes. Oncotarget. 2016 Nov 29;7(48):79706-21.   PMCID: PMC5346746
Zibelman M, Plimack ER. Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm. Oncology (Williston Park). 2016 Feb;30(2):160-2, 176.
Kwon Y, Smith BD, Zhou Y, Kaufman MD, Godwin AK. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Oncogene. 2015 Jan;34(2):144-53.   PMCID: PMC4067476
Zhang I, Zaorsky NG, Palmer JD, Mehra R, Lu B. Targeting brain metastases in ALK-rearranged non-small-cell lung cancer. Lancet Oncol. 2015 Oct;16(13):e510-21.
Ali SM, Alpaugh RK, Downing SR, Stephens PJ, Yu JQ, Wu H, Buell JK, Miller VA, Lipson D, Palmer GA, Ross JS, Cristofanilli M. Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy. J Clin Oncol. 2014 Sep;32(25):e88-91.   PMCID: 4876358
Langan P, Sangha AK, Wymore T, Parks JM, Yang ZK, Hanson BL, Fisher Z, Mason SA, Blakeley MP, Forsyth VT, Glusker JP, Carrell HL, Smith JC, Keen DA, Graham DE, Kovalevsky A. L-Arabinose binding, isomerization, and epimerization by D-xylose isomerase: X-ray/neutron crystallographic and molecular simulation study. Structure (London, England : 1993). 2014 Sep 02;22(9):1287-300.
Prakash S, Singh R, Lodhi N. Histone demethylases and control of gene expression in plants. Cell Mol Biol (Noisy-le-grand). 2014 Dec 24;60(5):97-105.
Itakura A, Aslan JE, Kusanto BT, Phillips KG, Porter JE, Newton PK, Nan XL, Insall RH, Chernoff J, McCarty OJ. p21-Activated Kinase (PAK) Regulates Cytoskeletal Reorganization and Directional Migration in Human Neutrophils. Plos One. 2013 Sep;8(9):e73063.   PMCID: PMC 3760889
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term enzymology

enzymology metabolism genetics pathology drug effects drug therapy Signal Transduction Female antagonists & inhibitors therapeutic use Mice Tumor Cell Line physiology pharmacology administration & dosage chemistry Middle Aged Protein Kinase Inhibitors Tumor Microenvironment Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Transfection Phosphorylation Tumor Biomarkers Cell Movement Molecular Targeted Therapy Male Neoplasm Drug Resistance Autophagy Secreted Matrix Metalloproteinases Neoplastic Gene Expression Regulation Brain Enzyme Activation Cyclooxygenase 2 Synapses p21-Activated Kinases Disease Progression Inbred C57BL Mice Proto-Oncogene Proteins c-met Apoptosis adverse effects Lung Neoplasms Fibroblasts Celecoxib Disease-Free Survival Knockout Mice Neoplasm Invasiveness Mitogen-Activated Protein Kinases Cyclooxygenase 2 Inhibitors Cell Proliferation Melanoma Adult mortality human psychology Neoadjuvant Therapy Renal Cell Carcinoma Eukaryotic Initiation Factor-2 extracellular matrix Streptomyces Random Allocation Inflammation Enzymologic Gene Expression Regulation Cml RNA Interference matrix metalloproteinases HIV Integrase Inhibitors Xenograft Model Antitumor Assays Phenotype Kaplan-Meier Estimate Ovarian Neoplasms Neurodegenerative Diseases Receptor Protein-Tyrosine Kinases Chemical Models Pyrazines Nuclear Envelope SCID Mice Plant Proteins Ductal Carcinoma-Breast Genomics Urologic Neoplasms Molecular Dynamics Simulation Proton leak Neoplastic Stem Cells Mutation Histone Demethylases Proto-Oncogene Proteins c-abl Signal Transducing Adaptor Proteins Apoptosis Regulatory Proteins Small Cell Carcinoma 15-Lipoxygenase Cytoskeleton Experimental Leukemia DNA Methylation Skin Neoplasms protein-ligand binding Western Blotting Extracellular Matrix Reactive Oxygen Species neoplasm invasion MAP Kinase Signaling System Fear Rats Biocatalysis Intracellular Signaling Peptides and Proteins Cell Communication Animal model 80 and over Aged Amyloid beta-Peptides Molecular Models Cell Cycle Checkpoints JNK Mitogen-Activated Protein Kinases Breast Neoplasms Protein Multimerization secretion Activating Transcription Factor 4 HIV-1 Arachidonate 12-Lipoxygenase Carcinoma Non-Small-Cell Lung Carcinoma X-Ray Crystallography Electron transport chain (ETC) uncoupling Oxidative Stress Leupeptins Animal Disease Models Dinoprostone beta Catenin Aminopyridines Anilides Pyridazines deficiency Young Adult Cathepsins Nude Mice Randomized Controlled Trials as Topic Urothelium Sprague-Dawley Rats cell invasion Protein Transport Imidazoles biosynthesis Structure-Activity Relationship Treatment Outcome Cytosol Lamin Type B Stereoisomerism Experimental Melanoma Encephalitis protein-protein docking ErbB-2 Receptor
Last updated on Wednesday, August 12, 2020